A detailed history of Mv Capital Management, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Mv Capital Management, Inc. holds 8 shares of BMRN stock, worth $533. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Previous 10 20.0%
Holding current value
$533
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$69.02 - $93.84 $138 - $187
-2 Reduced 20.0%
8 $0
Q2 2024

Aug 01, 2024

BUY
$74.43 - $92.22 $372 - $461
5 Added 100.0%
10 $0
Q1 2024

Apr 18, 2024

BUY
$83.81 - $99.0 $83 - $99
1 Added 25.0%
5 $0
Q4 2023

Jan 29, 2024

BUY
$76.22 - $98.51 $304 - $394
4 New
4 $0
Q3 2018

Nov 06, 2018

SELL
$93.92 - $105.72 $46,960 - $52,860
-500 Closed
0 $0
Q1 2018

May 09, 2018

BUY
$77.67 - $92.63 $38,835 - $46,315
500 New
500 $41,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Mv Capital Management, Inc. Portfolio

Follow Mv Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mv Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mv Capital Management, Inc. with notifications on news.